HDAC9 and cancer: We believe that novel combination regimens of metal nanosystems and HDAC inhibitors such as AuNP and SAHA represent a highly versatile platform for next-generation radiosensitizing nanomedicines that can be exploited to attenuate cancer cell growth for an improved therapeutic outcome.